CCL27/CCL28–CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells

Authors:
Publisher website
Google Scholar
Abstract
Metastasis via the lymphatic vasculature is an important step in cancer progression. The formation of new lymphatic vessels (lymphangiogenesis), or remodeling of existing lymphatics, is thought to facilitate the entry and transport of tumor cells into lymphatic vessels and on to distant organs. The migration of lymphatic endothelial cells (LEC) toward guidance cues is critical for lymphangiogenesis. While chemokines are known to provide directional navigation for migrating immune cells, their role in mediating LEC migration during tumor-associated lymphangiogenesis is not well defined. Here, we undertook gene profiling studies to identify chemokine–chemokine receptor pairs that are involved in tumor lymphangiogenesis associated with lymph node metastasis. CCL27 and CCL28 were expressed in tumor cells with metastatic potential, while their cognate receptor, CCR10, was expressed by LECs and upregulated by the lymphangiogenic growth factor VEGFD and the proinflammatory cytokine TNFα. Migration assays demonstrated that LECs are attracted to both CCL27 and CCL28 in a CCR10-dependent manner, while abnormal lymphatic vessel patterning in CCR10-deficient mice confirmed the significant role of CCR10 in lymphatic patterning. In vivo analyses showed that LECs are recruited to a CCL27 or CCL28 source, while VEGFD was required in combination with these chemokines to enable formation of coherent lymphatic vessels. Moreover, tumor xenograft experiments demonstrated that even though CCL27 expression by tumors enhanced LEC recruitment, the ability to metastasize was dependent on the expression of VEGFD. These studies demonstrate that CCL27 and CCL28 signaling through CCR10 may cooperate with inflammatory mediators and VEGFD during tumor lymphangiogenesis. Significance: The study shows that the remodeling of lymphatic vessels in cancer is influenced by CCL27 and CCL28 chemokines, which may provide a future target to modulate metastatic spread.
Funding Information
  • Department of Health | National Health and Medical Research CouncilDepartment of Health | National Health and Medical Research Council (NHMRC) (487900)
  • Department of Health | National Health and Medical Research CouncilDepartment of Health | National Health and Medical Research Council (NHMRC) (487900)
  • Department of Health | National Health and Medical Research CouncilDepartment of Health | National Health and Medical Research Council (NHMRC) (1053535)
  • Department of Health | National Health and Medical Research CouncilDepartment of Health | National Health and Medical Research Council (NHMRC) (487901)
  • Department of Health | National Health and Medical Research CouncilDepartment of Health | National Health and Medical Research Council (NHMRC) (1053535)
  • Department of Health | National Health and Medical Research CouncilDepartment of Health | National Health and Medical Research Council (NHMRC) (1053535)

This publication has 56 references indexed in Scilit: